Switch to:

Key Ratios

New Key Statistics Module, Z-Score and F-Score
Market Cap $M566Revenue (TTM) $M--Net Margin (%)--Altman Z-Score
Enterprise Value $M-25.8EPS (TTM) $--Operating Margin %--Piotroski F-Score--
P/E(ttm)27.6Beneish M-Score--Pre-tax Margin (%)--Higher ROA y-yN
Price/Book2.910-y EBITDA Growth Rate %--Quick Ratio--Cash flow > EarningsN
Price/Sales--5-y EBITDA Growth Rate %--Current Ratio--Lower Leverage y-yN
Price/Free Cash Flow--y-y EBITDA Growth Rate %--ROA % (ttm)--Higher Current Ratio y-yN
Dividend Yield %1.0PEG--ROE % (ttm)--Less Shares Outstanding y-yN
Payout Ratio %--Shares Outstanding M3,950,000ROIC % (ttm)--Gross Margin Increase y-yN

Gurus Latest Trades with IHE

Number of guru portfolios checked: 68.
No Entry found in the selected group of Gurus. You can

IHE is held by these investors:

No Entry found in the selected group of Gurus. You can
Premium Most recent portfolio changes are included for Premium Members only!

IHE: Insider Buys/Sells

Click Here for All Insider Trades.
InsiderPosition Date Trades Shares Trade Price ($) Change (%) Details
BEST, SIMON GEOFFREYDirector 2016-10-07Buy2,750$2.934793.86view
Camilli, Kathleen MaryDirector 2016-10-07Buy5,000$4.992773.55view
Breault, Robert PaulDirector 2016-10-07Sell68,500$0.7120095.77view
Meade, Harlan DonnleyDirector, Senior Officer 2016-10-07Buy3,000$0.1689518.75view
Lemasson, ClaudeDirector, Senior Officer 2016-10-07Buy100,000$0.817823.75view
ESTEPA, JORGEDirector or Senior Officer of 10% Security Holder, 2016-10-07Buy3,500$0.435747.5view
Griffiths, Richard Ian10% Security Holder 2016-10-07Buy89,500$035747.5view
Hinchcliffe, Robert10% Security Holder, Director, Senior Officer 2016-10-07Buy3,500$0.4432488.64view
Reeson, DouglasDirector, Senior Officer 2016-10-07Buy15,000$0.08179137.5view
Anderson, Christopher RossDirector 2016-10-07Buy28,000$0.14102321.43view

Quarterly/Annual Reports about IHE:

    News about IHE:

    Articles On GuruFocus.com
    No related article found.

    More From Other Websites
    A Look at Johnson & Johnson’s Segment-Wise Performance in 3Q16 Oct 21 2016
    Pfizer’s Divestment of Hospira Infusion Systems Oct 14 2016
    Medicare Negotiations Would Lead to Huge Cost Savings Oct 03 2016
    Analyzing Donald Trump’s Free-Market Healthcare Sep 30 2016
    How Does Hillary Clinton Plan to Tame Drug Prices? Sep 30 2016
    Generic Drugs Are Crucial in Cost Savings and Accessibility Sep 30 2016
    Getting Into The Drug Business: From NDAs To PDUFA Dates Sep 27 2016
    The Zacks Analyst Blog Highlights: Powershares Dynamic Pharmaceuticals ETF, SPDR S&P Pharmaceuticals... Sep 12 2016
    Will a Clinton Presidency Spell Doom for Pharma ETFs? Sep 09 2016
    Why Pfizer’s Vaccines Business Is Declining Sep 01 2016
    Will Xtandi Fuel Pfizer’s Top-Line Growth? Aug 31 2016
    Biotech Leads the Way in Health Care Stocks to Boost 401(k) Returns Aug 31 2016
    Analyzing Johnson & Johnson’s Business Segments Aug 30 2016
    Pfizer’s Products with Decreasing Revenues Aug 11 2016
    Pharma ETFs Soaring on Solid Q2 Earnings Aug 03 2016
    Trending on ETFdb.com: Emerging Markets and Dividend Kings Garner Interest Jun 02 2016
    Government Study: Cellphone Radiation Linked To Cancer May 27 2016
    Mudslinging Over Valeant Pharmaceuticals May 07 2016

    Add Notes, Comments

    If you want to ask a question or report a bug, please create a support ticket.
    Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
    GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)